These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2568405)

  • 1. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment.
    Johannessen JN; Chiueh CC; Bacon JP; Garrick NA; Burns RS; Weise VK; Kopin IJ; Parisi JE; Markey SP
    J Neurochem; 1989 Aug; 53(2):582-9. PubMed ID: 2568405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents.
    Fuller RW; Steranka LR
    Life Sci; 1985 Jan; 36(3):243-7. PubMed ID: 3871244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral metabolic effects of monoamine oxidase inhibition in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine acutely treated monkeys.
    Palombo E; Porrino LJ; Crane AM; Bankiewicz KS; Kopin IJ; Sokoloff L
    J Neurochem; 1991 May; 56(5):1639-46. PubMed ID: 2013759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Pileblad E; Carlsson A
    Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN; Sobotka TJ; Weise VK; Markey SP
    J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
    Irwin I; Langston JW
    Life Sci; 1985 Jan; 36(3):207-12. PubMed ID: 3871240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
    Muramatsu Y; Kurosaki R; Mikami T; Michimata M; Matsubara M; Imai Y; Kato H; Itoyama Y; Araki T
    Metab Brain Dis; 2002 Sep; 17(3):169-82. PubMed ID: 12322787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro.
    Bocchetta A; Piccardi MP; Del Zompo M; Pintus S; Corsini GU
    J Neurochem; 1985 Sep; 45(3):673-6. PubMed ID: 3928808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS; Denaro FJ
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Cohen G; Mytilineou C
    Life Sci; 1985 Jan; 36(3):237-42. PubMed ID: 3917526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey.
    Hartvig P; Larsson BS; Lindberg BS; Oreland L; Gullberg P; Långström B; Rimland A; Lundqvist H; Malmborg P; Lindquist NG
    Acta Neurol Scand; 1986 Jul; 74(1):10-6. PubMed ID: 3490110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine synthesis and release in the rabbit retina in vitro.
    Ofori S; Schorderet M
    Neuropharmacology; 1987 Nov; 26(11):1607-10. PubMed ID: 3501550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.